Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Anticoagulants Market Portraiture
2.2. Global Anticoagulants Market, by Drug Class, 2017 (US$ Mn)
2.3. Global Anticoagulants Market, by Application, 2017 (US$ Mn)
2.4. Global Anticoagulants Market, by Geography, 2017 (US$ Mn)
Chapter 3. Anticoagulants: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Anticoagulants Market, by Key Players, 2017
Chapter 4. Global Anticoagulants Market, by Drug Class, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Novel Oral Anticoagulants (NOACs)
4.3. Vitamin K Antagonists
4.4. Heparins & Low Molecular Weight Heparins (LMWH)
4.5. Antiplatelet Agents
4.6. Thrombolytic Agents
4.7. Direct Thrombin Inhibitors
4.8. Pipeline Analysis (Forecast for Phase III drugs till 2026)
Chapter 5. Global Anticoagulants Market, by Application Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Atrial Fibrillation & Heart Attacks
5.3. Strokes
5.4. Deep Vein Thrombosis (DVT)
5.5. Pulmonary Embolism
Chapter 6. Global Anticoagulants Market, by Geography, 2016 – 2026 (US$ Mn)
6.1. North America Anticoagulants Market Analysis, 2016 – 2026
6.1.1. North America Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.1.2. North America Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.1.3. North America Anticoagulants Market, by Country, 2016 – 2026 (US$ Mn)
6.1.3.1. U.S.
6.1.3.2. Canada
6.2. Europe Anticoagulants Market Analysis, 2016 – 2026
6.2.1. Europe Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.2.2. Europe Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. Europe Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.2.3.1. U.K.
6.2.3.2. Germany
6.2.3.3. Rest of Europe
6.3. Asia Pacific Anticoagulants Market Analysis, 2016 – 2026
6.3.1. Asia Pacific Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.3.2. Asia Pacific Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Asia Pacific Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. China
6.3.3.2. Japan
6.3.3.3. Rest of Asia Pacific
6.4. Latin America Anticoagulants Market Analysis, 2016 – 2026
6.4.1. Latin America Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.4.2. Latin America Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Latin America Anticoagulants Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Middle East & Africa Anticoagulants Market, 2016 – 2026
6.5.1. Middle East & Africa Anticoagulants Market, by Drug Class, 2016 – 2026 (US$ Mn)
6.5.2. Middle East & Africa Anticoagulants Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Middle East & Africa Anticoagulants Market, by Region, 2016 – 2026 (US$ Mn)
6.5.3.1. GCC
6.5.3.2. Rest of Middle East & Africa
Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Internation GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Bayer AG
7.3. Johnson & Johnson, Inc.
7.4. Bristol-Myers Squibb Company
7.5. Pfizer, Inc.
7.6. Daiichi-Sankyo Company Limited
7.7. Portola Pharmaceuticals, Inc.
7.8. Sanofi S.A.
7.9. Aspen Holdings
7.10. GlaxoSmithKline Plc
List of Figures
FIG 1. Anticoagulants Market: Research Methodology
FIG 2. Anticoagulants: Market Segmentation
FIG 3. Global Anticoagulants Market, by Drug Class, 2017 (US$ Mn)
FIG 4. Global Anticoagulants Market, by Application Type, 2017 (US$ Mn)
FIG 5. Global Anticoagulants Market, by Geography, 2017 (US$ Mn)
FIG 6. Attractive Investment Proposition, by Geography, 2017
FIG 7. Competitive Analysis: Global Anticoagulants Market, by Key Players, 2017
FIG 8. Global Novel Oral Anticoagulants (NOACs) Market, 2016-2026 (US$ Mn)
FIG 9. Global Vitamin K Antagonist Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 10. Global Heparins & Low Molecular Weight Heparins (LMWH) Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 11. Global Antiplatelet Agents Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 12. Global Thrombolytic Agents Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 13. Global Direct Thrombin Inhibitors Drug Class in Anticoagulants Market, 2016-2026 (US$ Mn)
FIG 14. Global Anticoagulant Market for Atrial Fibrillation & Heart Attacks, 2016-2026(US$ Mn)
FIG 15. Global Anticoagulant Market for Strokes, 2016-2026(US$ Mn)
FIG 16. Global Anticoagulant Market for Deep Vein Thrombosis (DVT), 2016-2026(US$ Mn)
FIG 17. Global Anticoagulant Market for Pulmonary Embolism, 2016-2026(US$ Mn)
FIG 18. U.S. Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 19. Canada Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 20. U.K. Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 21. Germany Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 22. Rest of Europe Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 23. China Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 24. Japan Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Asia Pacific Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 26. Brazil Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 27. Mexico Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 28. Rest of Latin America Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 29. GCC Anticoagulant Market, 2016-2026 (US$ Mn)
FIG 30. Rest of Middle East & Africa Anticoagulant Market, 2016-2026 (US$ Mn)
List of Tables
TABLE 1 Global Anticoagulant Market Portraiture
TABLE 2 Global Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 3 Global Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Anticoagulant Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 6 North America Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Anticoagulant Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Anticoagulant Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East & Africa Anticoagulant Market, by Drug Class, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East & Africa Anticoagulant Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East & Africa Anticoagulant Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Internation GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Johnson & Johnson, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Daiichi-Sankyo Company Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Portola Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Aspen Holdings: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)